Three things to know:
1. The company requested approval for an updated package insert that includes 24-month follow-up data from subjects in the original clinical study.
2. i-Factor is a peptide enhanced bone graft that Cerapedics commercialized in 2016.
3. The biologic bone graft incorporates a small peptide as an attachment factor to stimulate the natural bone healing process.
More articles on biologics:
2 hospitals losing neurosurgery residency programs
Rothman, Carrum Health partner to expand healthcare benefits into tri-state area
Nexxt Spine to expand headquarters — 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
